Immunotherapy combining allergen with low-dose IL-2 to generate antigen specific regulatory T cells

被引：0
|
作者：
Moguel, Helena [1 ]
Vigneron, James [1 ]
Gouritin, Bruno [1 ]
Vantomme, Helene [2 ,3 ]
Klatzmann, David [2 ,3 ]
Bellier, Bertrand [1 ]
机构：
[1] Sorbonne Univ, INSERM, UMR S 959, Immunol Immunopathol Immunotherapy I3, F-75005 Paris, France
[2] Hop La Pitie Salpetriere, AP HP, Biotherapy CIC BTi, F-75651 Paris, France
[3] Hop La Pitie Salpetriere, AP HP, Inflammat Immunopathol Biotherapy Dept DHU i2, F-75651 Paris, France
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2021年 / 51卷
关键词：
Animal models; immune regulation and therapy; immunotherapy;
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P-0138
引用
收藏
页码：387 / 387
页数：1
相关论文
共 50 条
  • [21] T regulatory cells in allergen-specific immunotherapy
    Verhagen, J
    Taylor, A
    Blaser, K
    Akdis, M
    Akdis, CA
    INTERNATIONAL REVIEWS OF IMMUNOLOGY, 2005, 24 (5-6) : 533 - 548
  • [22] EXPANSION OF REGULATORY T CELLS WITH ULTRA LOW-DOSE IL-2 AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Kennedy-Nasser, A. A.
    Ku, S.
    Chaiyarat, W.
    Foster, A.
    Savoldo, B.
    Yvon, E.
    Leung, K. S.
    Carrum, G.
    Kamble, R. T.
    Heslop, H. E.
    Brenner, M. K.
    Krance, R. A.
    Bollard, C. M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) : 134 - 134
  • [23] Low-dose IL-2 administration expands regulatory T cells and protects against experimental Sjogren's syndrome
    Yao, Yang
    Liang, Yichen
    Jin, Yuebo
    He, Jing
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (03) : S299 - S299
  • [24] Circulating regulatory T cells were absolutely decreased in dermatomyositis/polymyositis patients and restored by low-dose IL-2
    Zhang, Sheng-Xiao
    Wang, Jia
    Sun, He-Hua
    Zhang, Jia-Qian
    Liu, Guang-Ying
    Luo, Jing
    He, Pei-Feng
    Li, Xiao-Feng
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (08)
  • [25] IL-2 ameliorates chronic GVHD by inducing antigen-specific regulatory T cells
    Lohr, JG
    Knoechel, B
    Kahn, EC
    Abbas, AK
    BLOOD, 2004, 104 (11) : 726A - 726A
  • [26] ULTRA LOW-DOSE IL-2 MEDIATED EXPANSION OF REGULATORY T CELLS AS GVHD PROPHYLAXIS FOR RECIPIENTS OF ALLOGENEIC HEMATOPOIETIC STEM CELLS
    Ku, S.
    Kennedy-Nasser, A. A.
    Hazrat, Y.
    Melenhorst, J.
    Barrett, A.
    Ito, S.
    Durett, A. G.
    Foster, A.
    Savoldo, B.
    Yvon, E.
    Heslop, H. E.
    Carrum, G.
    Kamble, R. T.
    Brenner, M. K.
    Krance, R. A.
    Bollard, C. M.
    CYTOTHERAPY, 2013, 15 (04) : S41 - S42
  • [27] ULTRA LOW-DOSE IL-2 MEDIATED EXPANSION OF REGULATORY T CELLS AS GVHD PROPHYLAXIS FOR RECIPIENTS OF ALLOGENEIC HEMATOPOIETIC STEM CELLS
    Bollard, C.
    Kennedy-Nasser, A.
    Barrett, A. J.
    Ito, S.
    Yvon, E.
    Krance, R.
    Leung, K.
    Heslop, H. E.
    Brenner, K.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S242 - S242
  • [28] ULTRA LOW-DOSE IL-2 MEDIATED EXPANSION OF REGULATORY T CELLS AS GVHD PROPHYLAXIS FOR RECIPIENTS OF ALLOGENEIC HEMATOPOIETIC STEM CELLS
    Kennedy-Nasser, A. A.
    Ku, S.
    Melenhorst, J.
    Barrett, J.
    Hazrat, Y.
    Durett, A. G.
    Foster, A.
    Savoldo, B.
    Yvon, E.
    Heslop, H. E.
    Carrum, G.
    Kamble, R. T.
    Brenner, M. K.
    Krance, R. A.
    Bollard, C. M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S358 - S358
  • [29] Selective IL-2 Responsiveness of Regulatory T Cells Through Multiple Intrinsic Mechanisms Supports the Use of Low-Dose IL-2 Therapy in Type 1 Diabetes
    Yu, Aixin
    Snowhite, Isaac
    Vendrame, Francesco
    Rosenzwajg, Michelle
    Klatzmann, David
    Pugliese, Alberto
    Malek, Thomas R.
    DIABETES, 2015, 64 (06) : 2172 - 2183
  • [30] Allergen-specific immunotherapy Regulatory T cells or allergen-specific IgG?
    Kuendig, Thomas M.
    Bachmann, Martin F.
    HUMAN VACCINES, 2010, 6 (08): : 673 - 675
12345